{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:00:19Z","timestamp":1776186019310,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1981,2,1]],"date-time":"1981-02-01T00:00:00Z","timestamp":349833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[1981,2]]},"DOI":"10.1016\/s0022-3476(81)80631-2","type":"journal-article","created":{"date-parts":[[2006,3,18]],"date-time":"2006-03-18T12:36:31Z","timestamp":1142685391000},"page":"173-179","source":"Crossref","is-referenced-by-count":109,"title":["The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis"],"prefix":"10.1016","volume":"98","author":[{"given":"Melvin I.","family":"Marks","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0022-3476(81)80631-2_bib1","first-page":"833","article-title":"Cystic fibrosis","volume":"113","author":"Woods","year":"1976","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib2","first-page":"7","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis","volume":"262","author":"Hoiby","year":"1977","journal-title":"Acta Pathol Microbiol Scand Suppl"},{"key":"10.1016\/S0022-3476(81)80631-2_bib3","first-page":"388","article-title":"The association of viral and mycoplasma infections with lower respiratory tract disease in patients with cystic fibrosis","volume":"6","author":"DeForest","year":"1972","journal-title":"Pediatr Res"},{"key":"10.1016\/S0022-3476(81)80631-2_bib4","first-page":"325","article-title":"Incidence of serum antibodies to several aspergillus species and to Candida albicans in cystic fibrosis","volume":"114","author":"Galant","year":"1976","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib5_1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM197608262950905","article-title":"Research in cystic fibrosis","volume":"295","author":"DiSant'Agnese","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/S0022-3476(81)80631-2_bib5_2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM197609022951005","article-title":"Research in cystic fibrosis","volume":"295","author":"DiSant'Agnese","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/S0022-3476(81)80631-2_bib5_3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM197609092951105","article-title":"Research in cystic fibrosis","volume":"295","author":"DiSant'Agnese","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/S0022-3476(81)80631-2_bib6","first-page":"594","article-title":"Extracellular toxins of Pseudomonas aeruginosa","volume":"130S","author":"Liu","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/IAI.23.1.150-159.1979","article-title":"Microscopic characterization of rabbit lung damage produced by Pseudomonas aeruginosa proteases","volume":"23","author":"Gray","year":"1979","journal-title":"Infect Immun"},{"key":"10.1016\/S0022-3476(81)80631-2_bib8","first-page":"89","article-title":"In vivo studies on protease and elastase from Pseudomonas aeruginosa","volume":"45","author":"Kawaharajo","year":"1975","journal-title":"Jpn J Exp Med"},{"key":"10.1016\/S0022-3476(81)80631-2_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/infdis\/138.1.49","article-title":"Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: demonstration by radioimmunoassay","volume":"138","author":"Klinger","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1172\/JCI109300","article-title":"Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man","volume":"63","author":"Pollack","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/S0022-3476(81)80631-2_bib11","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.1976.03270200028024","article-title":"Mucoid Pseudomonas aeruginosa","volume":"236","author":"Reynolds","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/S0022-3476(81)80631-2_bib12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/iai.28.2.546-556.1980","article-title":"Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis","volume":"28","author":"Lam","year":"1980","journal-title":"Infect Immun"},{"key":"10.1016\/S0022-3476(81)80631-2_bib13","first-page":"453","article-title":"A rat model of chronic respiratory infection with Pseudomonas aeruginosa","volume":"119","author":"Cash","year":"1979","journal-title":"Amer Rev Respir Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib14","article-title":"The role of mucoid strains of Pseudomonas in the etiology of pulmonary infections in cystic fibrosis patients","author":"Chan","year":"1979","journal-title":"Cystic Fibrosis Club Abs"},{"key":"10.1016\/S0022-3476(81)80631-2_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/infdis\/139.3.357","article-title":"Influence of mucoidy on antibody coating of Pseudomonas aeruginosa","volume":"139","author":"Marrie","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1203\/00006450-197909000-00030","article-title":"Inhibitory effect of cystic fibrosis serum on Pseudomonas phagocytosis by rabbit and human alveolar macrophages","volume":"13","author":"Thomassen","year":"1979","journal-title":"Pediatr Res"},{"key":"10.1016\/S0022-3476(81)80631-2_bib17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1172\/JCI107683","article-title":"Development of cellular and humoral immunity in the respiratory tract of rabbits to Pseudomonas lipopolysaccharide","volume":"53","author":"Reynolds","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1016\/S0022-3476(81)80631-2_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bmj.1.5955.423","article-title":"Immune complexes in cystic fibrosis","volume":"1","author":"McFarlane","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/S0022-3476(81)80631-2_bib19","article-title":"Immune complexes in cystic fibrosis","author":"Manthei","year":"1979","journal-title":"Cystic Fibrosis Club Abs"},{"key":"10.1016\/S0022-3476(81)80631-2_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3476(78)80496-X","article-title":"Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis. Relationship to status of pulmonary disease in sibling pairs","volume":"93","author":"Sorensen","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/S0022-3476(81)80631-2_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1749-6632.1974.tb41497.x","article-title":"Staphylococcus aureus: Some host-parasite interactions","volume":"236","author":"Kapral","year":"1974","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S0022-3476(81)80631-2_bib22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0140-6736(69)91536-0","article-title":"Bronchial infection in cystic fibrosis","volume":"1","author":"May","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/S0022-3476(81)80631-2_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/IAI.11.2.313-319.1975","article-title":"Cell-mediated immune phenomena induced by lymphokines from splenic lymphocytes of mice with chronic staphylococcal infection","volume":"11","author":"Baughn","year":"1975","journal-title":"Infect Immun"},{"key":"10.1016\/S0022-3476(81)80631-2_bib24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI108971","article-title":"The key role of peptidoglycan in the opsonization of Staphylococcus aureus","volume":"61","author":"Peterson","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/S0022-3476(81)80631-2_bib25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/IAI.15.3.760-764.1977","article-title":"Effect of protein A on staphylococcal opsonization","volume":"15","author":"Peterson","year":"1977","journal-title":"Infect Immun"},{"key":"10.1016\/S0022-3476(81)80631-2_bib26","first-page":"997","article-title":"Quantitative culture and gram stain of sputum in pneumonia","volume":"118","author":"Guckian","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-3476(79)80785-4","article-title":"A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis","volume":"95","author":"Loening-Baucke","year":"1979","journal-title":"J Pediatr"},{"key":"10.1016\/S0022-3476(81)80631-2_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3476(80)80155-7","article-title":"Is antipseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? A controlled study comparing cloxacillin alone to a combination of carbenicillin-gentamicin","volume":"97","author":"Beaudry","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/S0022-3476(81)80631-2_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/infdis\/135.5.828","article-title":"Pharmacokinetics of methicillin in patients with cystic fibrosis","volume":"135","author":"Yaffe","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1542\/peds.60.3.372","article-title":"Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis","volume":"60","author":"Lau","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/S0022-3476(81)80631-2_bib31","series-title":"Proceedings of the 18th Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"Double-blind controlled trial of tobramycin or placebo therapy for acute pulmonary exacerbations of cystic fibrosis","author":"Wientzen","year":"1978"},{"key":"10.1016\/S0022-3476(81)80631-2_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/infdis\/119.6.597","article-title":"Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia","volume":"119","author":"Tillotson","year":"1969","journal-title":"J Infect Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib33","article-title":"Safety of once daily therapy with high-dose tobramycin","author":"Powell","year":"1979","journal-title":"Cystic Fibrosis Club Abs"},{"key":"10.1016\/S0022-3476(81)80631-2_bib34","article-title":"Safety of long duration intravenous (IV) needles for administration of antibiotics to patients with cystic fibrosis (CF)","author":"Hodder","year":"1979","journal-title":"Cystic Fibrosis Club Abs"},{"key":"10.1016\/S0022-3476(81)80631-2_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1542\/peds.54.3.358","article-title":"Outpatient intravenous medications in the management of cystic fibrosis","volume":"54","author":"Rucker","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/S0022-3476(81)80631-2_bib36","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/AAC.7.5.596","article-title":"Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin, polymyxin B, and carbenicillin","volume":"7","author":"D'Amato","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0022-3476(81)80631-2_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jac\/4.3.233","article-title":"Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid form to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro","volume":"4","author":"Govan","year":"1978","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0022-3476(81)80631-2_bib38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/140.6.873","article-title":"Multiple isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis","volume":"140","author":"Thomassen","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/jcm.9.1.72-78.1979","article-title":"Multiple antibiotic susceptibilities and serotypes of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients","volume":"9","author":"Seale","year":"1979","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S0022-3476(81)80631-2_bib40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0022-3476(71)80401-8","article-title":"Carbenicillin and gentamicin: Pharmacologic studies in patients with cystic fibrosis and Pseudomonas pulmonary infections","volume":"79","author":"Marks","year":"1971","journal-title":"J Pediatr"},{"key":"10.1016\/S0022-3476(81)80631-2_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-73-2-179","article-title":"Carbenicillin: A clinical and laboratory evaluation","volume":"73","author":"Marks","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0022-3476(81)80631-2_bib42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/infdis\/140.2.252","article-title":"Summary of a workshop on infections in patients with cystic fibrosis","volume":"140","author":"Pennington","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1016\/S0022-3476(81)80631-2_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000237895","article-title":"Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis","volume":"26","author":"Michalesen","year":"1980","journal-title":"Chemotherapy"},{"key":"10.1016\/S0022-3476(81)80631-2_bib44","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/AAC.13.6.1052","article-title":"Incidence and characteristics of antibiotic-tolerant strains of Staphylococcus aureus","volume":"13","author":"Bradley","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0022-3476(81)80631-2_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jama.1978.03290010034018","article-title":"Pseudomonas colonization in cystic fibrosis. A study of 160 patients","volume":"240","author":"Kulczcki","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/S0022-3476(81)80631-2_bib46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/AAC.10.3.399","article-title":"Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa","volume":"10","author":"Marks","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0022-3476(81)80631-2_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM197702172960701","article-title":"Controlled comparison of amikacin and gentamicin","volume":"296","author":"Smith","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/S0022-3476(81)80631-2_bib48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(79)91580-0","article-title":"Nephrotoxicity with gentamicin or tobramycin","volume":"11","author":"Plaut","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/S0022-3476(81)80631-2_bib49","article-title":"Hearing in patients with cystic fibrosis (CF) following longerm tobramycin administration","author":"Christy","year":"1979","journal-title":"Cystic Fibrosis Club Abs"},{"key":"10.1016\/S0022-3476(81)80631-2_bib50","article-title":"Delayed onset and reversible vestibulotoxicity of high dose tobramycin therapy to children with cystic fibrosis","author":"Rabin","year":"1979","journal-title":"Cystic Fibrosis Club Abs"},{"key":"10.1016\/S0022-3476(81)80631-2_bib51","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1128\/AAC.14.6.807","article-title":"HR 756, a highly active cephalosporin: Comparison with cefazolin and carbenicillin","volume":"14","author":"Wise","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0022-3476(81)80631-2_bib52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/AAC.16.3.297","article-title":"LY-127935: A novel beta-lactam antibiotic with unusual antibacterial activity","volume":"16","author":"Trager","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0022-3476(81)80631-2_bib53","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1128\/AAC.16.6.731","article-title":"In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin","volume":"16","author":"Matsubara","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0022-3476(81)80631-2_bib54","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/AAC.14.6.919","article-title":"Comparative evaluation of piperacillin in vitro","volume":"14","author":"Dickinson","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0022-3476(81)80631-2_bib55","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/AAC.15.3.396","article-title":"Comparative study of antipseudomonas activity of azlocillin, mezlocillin, and ticarcillin","volume":"15","author":"Coppens","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0022-3476(81)80631-2_bib56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3476(77)80790-7","article-title":"Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicin","volume":"90","author":"Parry","year":"1977","journal-title":"J Pediatr"},{"key":"10.1016\/S0022-3476(81)80631-2_bib57","first-page":"451","article-title":"AT-2266, a new oral antipseudomonal agent","volume":"1","author":"Shimizu","year":"1979","journal-title":"Current Chemotherapy and Infectious Disease. Proceedings 11th ICC and 19th ICAAC\u2014Amer Soc Microbiol"},{"key":"10.1016\/S0022-3476(81)80631-2_bib58","first-page":"107","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis","volume":"85","author":"Hoiby","year":"1977","journal-title":"Acta Path Microbiol Scand"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347681806312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347681806312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T11:02:05Z","timestamp":1706958125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347681806312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1981,2]]}},"alternative-id":["S0022347681806312"],"URL":"https:\/\/doi.org\/10.1016\/s0022-3476(81)80631-2","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[1981,2]]}}}